Posters SUNDAY 19th

P-1
DISTRIBUTION OF ANAPLASMA PHAGOCYTOPHILUM AND "IXODES OVATUS" EHRLICHIA SP. IN IXODES RICINUS IN BRITTANY, FRANCE.
K. Matsumoto*, G. Joncour, P. Lamada, B. Caro, A. Le Dret, D. Raoult, and P. Brouqui

P-2
HIGHLY VARIABLE YEAR TO YEAR PREVALENCE OF ANAPLASMA PHAGOCYTOPHILUM IN IXODES RICINUS TICKS IN NORTHEASTERN POLAND. FOUR YEARS FOLLOW-UP.
Anna Grzeszczuk*,

P-3
ESTIMATION OF THE PREVALENCE OF TICK INFECTION BY MEMBERS OF ANAPLASMATACEAE FAMILY IN TUNISIA.
Youmna M'Ghirbi, Ali Bouattour* and Danièle Postic

P-4
EPIDEMIOLOGICAL SURVEY OF EHRLICHIA CANIS AND RELATED SPECIES INFECTION IN DOGS IN EASTERN SUDAN.
Hisashi Inokuma, Maremichi Oyamada, Bernard Davoust, Mickaël Boni, Jacques Dereure, Bruno Bucheton, Awad Hammad, Malaika Watanabe, Kazuhito Itamoto, Masaru Okuda, and Philippe Brouqui

P-5
SURVEYS ON SEROPREVALENCE OF CANINE MONOCYTIC EHRLICHIOSIS AMONG DOGS LIVING IN THE IVORY COAST AND GABON AND EVALUATION OF A QUICK COMMERCIAL TEST KIT DOT-ELISA.
Bernard Davoust*, Olivier Bourry, José Gomez, Laurent Lafay, Fanny Casali, Eric Leroy and Daniel Parzy

P-6
DETECTION OF EHRLICHIA SPP. INFECTING DOGS IN CAMEROON.
Lucy M. Ndip*, Roland N. Ndip, Seraphine N. Esemu, Veronica l. Dickmu, Eric B. Fokam, David H. Walker and Jere W. McBride

P-7
EXPERIMENTAL INFECTIONS IN DOGS WITH EHRLICHIA CANIS STRAIN BORGO 89.
Stéphanie Jouret-Gourjault, Daniel Parzy and Bernard Davoust*

P-8
RESERVOIR COMPETENCY OF GOATS FOR ANAPLASMA PHAGOCYTOPHILUM.
Robert F. Massung*, Michael L. Levin, Nathan J. Miller, and Thomas N. Mather

P-9
AN EPIDEMIOLOGICAL STUDY ON ANAPLASMA INFECTION IN CATTLE, SHEEP AND GOATS IN MASHHAD SUBURB, KHORASAN PROVINCE, IRAN. G.R. Razmi*, K. Dastjerdi, H. Hossieni, A. Naghibi, M.R. Aslani

P-10
ISOLATION OF ANAPLASMA PHAGOCYTOPHILUM STRAIN AP-VARIANT 1 IN A TICK-DERIVED CELL LINE.
Robert F. Massung*, Michael L. Levin, Ulrike G. Munderloh, David J. Silverman, Meghan J. Lynch, and Timothy J. Kurtti

P-12
UNIDIRECTIONAL SUPPRESSION OF GENOTYPES IN ANAPLASMA PHAGOCYTOPHILUM INFECTED LAMBS.
S. Stuen*, H. Dahl, K. Bergström, T. Moum

P-13
MECHANISMS OF IMMUNOLOGICAL CONTROL OF ANAPLASMA PHAGOCYTOPHILUM IN MICE.
Friederike D. von Loewenich*, Yvonne Kern, Christina Rinkler, and Christian Bogdan

P-14
CHANGES IN FERRITIN EXPRESSION ASSOCIATED WITH ANAPLASMA PHAGOCYTOPHILUM INFECTION.
Jason A. Carlyon*, Dara Ryan, Kristina Archer, and Erol Fikrig

P-15
P38 MAPK IS INVOLVED IN EARLY BUT NOT LATE NEUTROPHIL APOPTOSIS INHIBITION BY ANAPLASMA PHAGOCYTOPHILUM.
K.S. Choi and J.S. Dumler*

P-16
PLATELET DYSFUNCTION AND ACTIVATION AFTER ASSOCIATION WITH ANAPLASMA PHAGOCYTOPHILUM IN VITRO.
D. L. Borjesson*, and R. Feferman

P-17
ANAPLASMA PHAGOCYTOPHILUM-INFECTION REDUCES EXPRESSION OF PHAGOCYTOSIS-RELATED RECEPTORS ON NEUTROPHILS.
Justin W.A. Garyu*, J.S. Dumler

P-18
ANKA OF ANAPLASMA PHAGOCYTOPHILUM IS TRANSLOCATED INTO THE HOST CELL NUCLEUS AND BINDS PUTATIVE MATRIX-ATTACHMENT REGIONS OF THE GENOMIC DNA.
Jose Carlos Garcia-Garcia*, Jinho Park, Ling Gao, Terumi Kohwi-Shigematsu, J. Stephen Dumler

P-19
TRANSPOSON-BASED MUTAGENESIS OF ANAPLASMA PHAGOCYTOPHILUM.
Jacob Ijdo*, Angel Mueller, Adam Carlson

P-20
CLEARANCE OF EHRLICHIA CHAFFEENSIS IN MHCII-DEFICIENT MICE.
S.K. Chapes*, E. Miller, C. Cheng and R.R. Ganta

P-22
ANALYSIS OF EHRLICHIAL P28 GENE EXPRESSION IN A MURINE MODEL OF PERSISTENT INFECTION.
Patricia A. Crocquet-Valdes*, Jere W. McBride, Hui-min Feng, Nahed Ismail, Melissa A. Small, Xue-jie Yu and David H. Walker

P-23
TISSUE INJURY IN THE MURINE MODEL OF GRANULOCYTIC ANAPLASMOSIS RELATES TO HOST INNATE IMMUNE RESPONSE AND NOT PATHOGEN LOAD.
Diana G. Scorpio*, J. Stephen Dumler, Christian Bogdan, and Friederike D. von Loewenich

P-24
HOST CELL-SPECIFIC PROTEIN EXPRESSION IN EHRLICHIA RUMINANTIUM.
Milagros Postigo*, Lesley Bell-Sakyi, Stuart Smith, Cornelis Bekker, Amar Taoufik, Ivan Morrison, Frans Jongejan

P-25
CYTOKINE RESPONSE IN EHRLICHIA CANIS-INFECTED DOGS.
Tomoko Tajima* and Yasuko Rikihisa

P-26
CYTOKINE GENE EXPRESSION BY PERIPHERAL BLOOD LEUKOCYTES IN DOGS EXPERIMENTALLY INFECTED WITH EHRLICHIA CANIS.
Ahmet Unver, Haibin Huang   and Yasuko Rikihisa*

P-28
THE EHRLICHIA CANIS MAJOR IMMUNOREACTIVE GLYCOPROTEIN (GP200) CONTAINS FOUR MAJOR B CELL EPITOPES DEFINED BY CARBOHYDRATE AND PEPTIDE DETERMINANTS.
Kimberly A. Nethery*, C. Kuyler Doyle, Xiaofeng Zhang, and Jere W. McBride

P-29
DISCOVERY OF MAJOR IMMUNOREACTIVE GLYCOPROTEIN ORTHOLOGS OF EHRLICHIA CANIS AND E. CHAFFEENSIS.
C. Kuyler Doyle*, Kimberly A. Nethery, Vsevolod L. Popov, and Jere W. McBride

P-30
EHRLICHIA CHAFFEENSIS AND GLYCOPROTEINS ELICIT MONOCYTE PRODUCTION OF INFLAMMATORY CHEMOKINES.
Jere W. McBride* and Xiaofeng Zhang

P-31
DIFFERENTIAL EXPRESSION OF MEMBERS OF THE ANAPLASMA MARGINALE MSP2 SUPERFAMILY.
Susan M. Noh*, Kelly A. Brayton, Donald P. Knowles, Jr., Guy H. Palmer

P-32
CLONING AND EXPRESSION OF 51 KDA ANTIGENIC PROTEIN OF NEORICKETTSIA RISTICII NR-JA1.
Myeong-Kyu Park, Eun-Ha Kim, Mae-Rim Cho, Ying-Hua Yi, Mi-Jin Lee, Devendra H. Shah, Jin-Ho Park, Bae-Keun Park and Joon-Seok Chae*

P-33
SEROPREVALENCE OF ANAPLASMA PHAGOCYTOPHILUM AMONG FORESTRY WORKERS IN NORTHERN AND NORTH-EASTERN POLAND.
, A. Grzeszczuk*, W. Kruminis-Lozowska, M. Racewicz, B. Kubica-Biernat

P-34
SEROLOGICAL EVALUATION OF ANAPLASMA PHAGOCYTOPHILUM INFECTION IN LIVESTOCK IN NORTHWESTERN SPAIN.
Inmaculada Amusategui, Ángel Sainz*, Miguel A. Tesouro

P-35
PREVALENCE AND INCIDENCE OF INFECTION WITH ANAPLASMA PHAGOCYTOPHILUM AMONG SLOVENE FORESTRY WORKERS DURING THE PERIOD OF TICK ACTIVITY.
Tereza Rojko*, T. Ursic, T. Avsic-Zupanc, M. Petrovec, F. Strle and S. Lotric-Furlan

P-36
ANAPLASMA PHAGOCYTOPHILUM INFECTION IN CATTLE IN FRANCE.
K. Matsumoto, G. Joncour, B. Davoust, P.H. Pitel, A. Chauzy, E. Collin, H. Morvan, N. Vassallo, P. Brouqui*

P-37
MOLECULAR EPIDEMIOLOGY OF HUMAN AND BOVINE ANAPLASMOSIS IN SOUTHERN EUROPE.
Victoria Naranjo*, Francisco Ruiz-Fons, Ursula Hofle, Isabel G. Fernández de Mera, Diego Villanúa, Consuelo Almazán, Alessandra Torina, Santo Caracappa, Katherine M. Kocan, Christian Gortázar, José de la Fuente

P-38
UNDERSTANDING THE MECHANISMS OF TRANSMISSION OF EHRLICHIA RUMINANTIUM AND ITS INFLUENCE ON THE STRUCTURE OF PATHOGENS POPULATIONS IN THE FIELD.
Nathalie Vachiéry*, Modestine Raliniaina, Frédéric Stachurski, Sophie Molia, Thierry Lefrançois and Dominique Martinez

P-41
HUMAN GRANULOCYTIC ANAPLASMOSIS: THE FIRST SPANISH CASE CONFIRMED BY PCR.
J.C. García*, M.J. Núñez, B. Castro, F.J. Fraile, M.A. López, M.C. Mella, A. Blanco, E. Loureiro, C. Sieira, A. Portillo, J.A. Oteo

P-42
HUMAN EXPOSURE TO ANAPLASMA PHAGOCYTOPHILUM IN PORTUGAL. A.S. Santos*, F. Bacellar, J.S. Dumler

P-43
TWO HUMAN CASES OF HUMAN GRANULOCYTIC EHRLICHIOSIS, CONFIRMED BY PCR, IN SARDINIA-ITALY.
S. Mastrandrea, M.S. Mura, S. Tola*, A. Tanda, R. Porcu, G. Masala

P-44
HUMAN GRANULOCYTIC EHRLICHIOSIS (HGE) IN NORTH-EASTERN ITALY. A. Beltrame, M. Ruscio, A. Arzese, G. Rorato, C. Negri, A. Londero, M. Crapis, P. Viale

P-45
EHRLICHIA CANIS DETECTION IN SYMPTOMATIC HUMANS IN VENEZUELA. Miriam Perez*, Mairim Bodor, Chunbin Zhang, Yasuko Rikihisa

P-46
HUMAN MONOCYTIC EHRLICHIOSIS AND HUMAN GRANULOCYTIC ANAPLASMOSIS IN THE UNITED STATES, 2001- 2002. Linda J. Demma*, R.C. Holman, J.H. McQuiston, J. W. Krebs, D.L. Swerdlow

P-47
MULTIPLEX DETECTION OF EHRLICHIA AND ANAPLASMA PATHOGENS IN VERTEBRATE AND TICK HOSTS BY REAL-TIME RT-PCR. Kamesh R. Sirigireddy*, Donald C. Mock and Roman R. Ganta

P-48
REAL-TIME PCR IN NATURAL AND EXPERIMENTAL EHRLICHIA CANIS INFECTION USING INVASIVELY AND NON-INVASIVELY OBTAINED SAMPLES. Gad Baneth*, Shimon Harrus, Frederic S. Ohnona, Yechiel Schlesinger

P-49
PROPHYLACTIC USE OF SUSTAINED-RELEASE DOXYCYCLINE BLOCKS TICK-TRANSMITTED INFECTION BY ANAPLASMA PHAGOCYTOPHILUM IN A MURINE MODEL. Robert F. Massung*, Nordin S. Zeidner, Marc C. Dolan, Dawn Roellig, Elizabeth Gabitzsch, Danielle R. Troughton, and Michael L. Levin

14:00 - 19:00        EVENING SESSION

P-50
DETECTION OF ANAPLASMA PHAGOCYTOPHILUM, COXIELLA BURNETII, RICKETTSIA SPP. AND BORRELIA BURGDORFERI S. L. IN TICKS, AND WILD-LIVING ANIMALS IN WESTERN AND MIDDLE SLOVAKIA.
K. Smetanová*, K. Schwarzová, E. Kocianová

P-51
ANTHROPOGENIC EFFECTS ON CHANGING OF Q-FEVER EPIDEMIOLOGY IN RUSSIA.
Nikolay Tokarevich*, Olga Freilikhman, Natalia Titova, Irina Zheltakova, Nina Rybakova, Evgeny Vorobeichikov

P-52
HUMAN COXIELLA BURNETII INFECTIONS IN PARTICULAR REGIONS OF BOSNIA AND HERZEGOVINA, 2002.

1*, , , , , , , ,

P-53
GIPUZKOA, BASQUE COUNTRY, SPAIN (1984-2004), A HIPERENDEMIC AREA OF Q FEVER.
M. Montes*, G. Cilla, D. Vicente, M. Ercibengoa, E. Perez-Trallero

P-54
NATURAL AND AGRICULTURAL FOCI OF THE MARSEILLE AND Q-FEVERS IN BULGARIA. E. Alexandrov*, N. Nedelchev, D. Alexandrova, S. Martinov, Z. Dimitrova, B. Kamarinchev

P-55
THE ROLE OF WIND IN THE OUTBREAK OF Q FEVER.
*, , , Ira Gjenero Margan, ,

P-56
EVALUATION OF LOW CONCENTRATION AEROSOL FOR INFECTING OF THE MAN BY Q FEVER PATHOGEN. Eugene Vorobeychikov1*, Ludmila Yakovleva, Alexander Vasilenko and Boris Nikolaev

P-57
PUBLIC-HEALTH PROBLEM OF ZOONOSES WITH EMPHASIS ON Q-FEVER. *, , ,

P-58
INCIDENCE OF OVINE ABORTION BY COXIELLA BURNETII IN NORTHERN SPAIN.
B. Oporto, J.F. Barandika, A. Hurtado, B. Moreno, G. Aduriz, A.L. García-Pérez*

P-59
DETECTION OF COXIELLA BURNETII IN MARKET CHICKEN EGGS AND MAYONNAISE.
Noriyuki Tatsumi*, Andreas Baumgartner, Ying Qiao, Ikkyu Yamamoto, Kazuo Yamaguchi

P-60
DEFECTIVE LEUCOCYTE TRANSENDOTHELIAL MIGRATION IN Q FEVER: ROLE OF IL-10.
S. Meghari*, D. Raoult and J.L. Mege

P-61
GENOME SEQUENCE OF TWO ENDOCARDITIS ISOLATES OF COXIELLA BURNETII.
P.A. Beare, S.F. Porcella, R. Seshardi, J.E. Samuel, and R.A. Heinzen*

P-62
TRANSCRIPTOME AND PROTEOME ANALYSIS OF COXIELLA BURNETII DEVELOPMENTAL FORMS.
S.A. Coleman*, P.A. Beare, S. F. Porcella, D. Sturdevant, D. Howe, E.R. Fischer, D.J. Meade, and R.A. Heinzen

P-63
FUR-REGULATED GENES IN COXIELLA BURNETII.
H.L. Briggs*, M.J. Wilson, R. Seshadri, and J.E. Samuel

P-64
C. BURNETII VIRULENCE IS ISOLATE GROUP SPECIFIC IN THE GUINEA PIG AEROSOL-CHALLENGE MODEL.
K.E. Russell-Lodrigue*, M.W.J. Poels, G.Q. Zhang, D.N. McMurray, J.E. Samuel

P-65
RECA IS ESSENTIAL FOR INTRACELLULAR SURVIVAL OF COXIELLA BURNETII.
K. Mertens*, L. Lantsheer and J. E. Samuel

P-66
COMPARATIVE VIRULENCE OF PHASE I AND II COXIELLA BURNETII IN IMMUNODEFICIENT MICE.
Masako Andoh*, Kasi Russel-Lodrigue, Guoquan Zhang, James Samuel

P-67
MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A NOVEL COXIELLA FROM CARIOS CAPENSIS.
Will K. Reeves*, Amanda D. Loftis, Rachael A. Priestley, William Wills, Felicia Sanders, Gregory A. Dasch

P-68
SEROTESTING OF HUMAN Q-FEVER PREVALENCE IN WIDER AREA OF BOSNIA AND HERZEGOVINA.
*, ,

P-69
ANALYSIS OF COXIELLA BURNETII FROM HUMANS AND RESERVOIRS IN SPAIN.
I. Jado*, M. Bolaños, A. García Pérez, M. Quevedo, A. Tellez, R. Escudero, A.M. Martín Sánchez, B. Oporto, C. García Amil, E. Santana Rodríguez, M. Rodríguez Vargas, P. Anda

P-70
Q-FEVER DURING PREGNANCY.
R. Komitova*, M. Teocharova, E. Aleksandrov

P-71
ESTABLISHMENT OF A GENOTYPING SCHEME FOR COXIELLA BURNETII. Sanela Svraka*, Rudolf Toman, Ludovit Skultety, Katarina Slaba, W.L. Homan

P-72
IDENTIFICATION AND CHARACTERIZATION OF COXIELLA BURNETII STRAINS AND ISOLATES USING MONOCLONAL ANTIBODIES.
Z. Sekeyová*,

P-73
GENOME PROFILING OF COXIELLA BURNETII BY DNA HYBRIDIZATION TO A CUSTOM HIGH DENSITY MICROARRAY.
P.A. Beare, J.E. Samuel, K. Virtaneva, S.F. Porcella, R.A. Heinzen

P-74
COMPARISON OF FOUR COMMERCIALLY AVAILABLE ASSAYS FOR THE DETECTION OF IGM PHASE II ANTIBODIES TO COXIELLA BURNETII IN THE DIAGNOSIS OF ACUTE Q FEVER.
Dimitrios Frangoulidis*, Elmar Schröpfer, Sascha Al Dahouk, Herbert Tomaso and Hermann Meyer

P-75
IDENTIFICATION, CLONING AND EXPRESSION OF POTENTIAL DIAGNOSTIC MARKERS FOR Q FEVER.
C.C. Chao*, H.W. Chen, X. Li, W.B. Xu, B. Hanson, and W.M. Ching

P-77
DIAGNOSIS OF COXIELLA BURNETII PERICARDITIS BY USING A SYSTEMATIC PRESCRIPTION KIT IN CASE OF PERICARDIAL EFFUSION.
PY. Levy*, G. Habib, JL Bonnet, P. Djiane, D. Raoult

P-78
EVALUATION OF A REAL-TIME PCR ASSAY TO DETECT COXIELLA BURNETII.
S. Klee*, H. Ellerbrok, J. Tyczka, T. Franz and B. Appel

P-79
BALB/C MOUSE MODEL AND REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION FOR EVALUATION OF THE IMMUNOPROTECTIVITY AGAINST Q FEVER.
Jingbo Zhang, Bohai Wen*, Meiling Chen, Wenjin Wei, and Dongsheng Niu

P-80
DIAGNOSIS OF Q FEVER INFECTION BY PCR ON SERA DURING A RECENT OUTBREAK IN RURAL SOUTH AUSTRALIA.
Mark Turra*, Grace Chang, Daryn Whybrow, Geoff Higgins and Ming Qiao

P-81
Q FEVER PROPHYLAXIS, MARKERS OF PERSISTENT INFECTION & VARIATIONS IN IMMUNE FUNCTION GENES IN SUBJECTS WITH CHRONIC Q FEVER" EXIT SUMMARY 1981 - 2004.
Marmion B, Harris R*, Storm P, Helbig K, Penttila I & Semendric L & Q Fever Research Group Adelaide

P-82
IN VITRO SUSCEPTIBILITIES OF 13 NEW ISOLATES OF COXIELLA BURNETII TO ERYTHROMYCIN, TELITHROMYCIN, AND DOXYCYCLINE USING REAL-TIME QUANTITATIVE PCR.
J.M. Rolain, F. Lambert, and D. Raoult*

P-83
CORRELATION BETWEEN MIC TO DOXYCYCLINE AND TREATMENT OUTCOME IN Q FEVER ENDOCARDITIS.
J.M. Rolain, A. Boulos, M.N. Mallet, and D. Raoult*

P-84
Q FEVER PNEUMONIA TREATMENT.
M. Morovic

P-85
SENSITIVITY OF COXIELLA BURNETII TO DISINFECTANTS.
Barbara Tadeusiak, Stanislawa Tylewska-Wierzbanowska*